Archive - FutureFemHealth Pro

FutureFemHealth Pro is built to help you understand what’s happening in women’s health and what it means.

Explore our FutureFemHealth Pro archive below.

Already a Pro subscriber? Choose any article below to read. If prompted, sign in using the email address associated with your subscription - no password required.

Not yet part of FutureFemHealth Pro? Upgrade here.

45 deals and $456m: what Q3 tells us about women’s health funding

The new push to build the missing foundations for women’s health research

What if vaginal microbiome testing becomes routine?

What if the next women’s health diagnostic doesn’t require another test?

Is maternal birth injury prevention becoming an investable category?

Reimbursement has moved up the women’s health agenda. Here’s why.

What happened to the women’s health market for women 65+?

Before IVF: the emerging market for a shorter path to pregnancy

The peptide precedent: what women’s health should really be watching

When women's health stops looking like women's health

H1 2026 M&A Analysis: what this year’s deals tell us about the future of women’s health

Q2 2026: women's health funding in review

Beyond the prescription: The GLP-1 support economy in women’s health

What actually counts as continuous hormone monitoring? Why the industry can’t agree

What it takes to get reimbursed in women’s health - the Hello Inside story

The messy middle of equity and inclusion in femtech

How urinary incontinence became a real healthcare market

Why women’s health is building a new ‘trust layer’

Is Organon’s acquisition good for women’s health - or just good business?

Why the bone health market is moving earlier

Q1 funding: what $1.24b into women’s health really tells us

The PCOS opportunity: a deep dive into this unsolved area of women’s health

Menstrual blood diagnostics in 2026: what's changing - and what we're tracking